Course Overview
PROGRAM OVERVIEW
Adult growth hormone deficiency (AGHD), a medical condition that results from a lack of growth hormone in adults, has many contributing factors. AGHD symptoms are often vague and non-specific, making clinical diagnosis challenging. To improve patient outcomes, it is essential that healthcare providers understand the significant clinical challenges and identify and diagnose AGHD in a timely manner. Treatment should be individualized based on symptoms, underlying cause and other medical history. Also, patients need education and support to help them adhere to their treatment plan and manage any side effects. At this symposium, experts will review these issues and share best practices for diagnosing, treating, and supporting patients with AGHD.
PROGRAM AGENDA
Introductions, Overview and Pre-Event Polling Questions
– Maria Fleseriu, MD, FACE
Diagnosis and Who to Test for Adult Growth Hormone Deficiency
– Julie Silverstein, MD
Available GH Replacement Therapies, Efficacy and Safety
– Gudmundur Johannsson, MD, PhD
Monitoring and Ongoing Management of Adult Growth Hormone Deficiency
– Andrew R. Hoffman, MD
Post-Event Polling Questions, Open Discussion and Audience Questions
– Faculty Panel
Upon completion of this educational activity, participants should be able to:
Describe the comorbidities associated with adult growth hormone deficiency (AGHD)
Explain how AGHD comorbidities contribute to mortality
Identify patients who are appropriate candidates for diagnostic screening and recognition of early AGHD
Summarize AGHD testing protocols
Review the safety and efficacy of AGHD treatment options
Explain the ongoing management requirements for AGHD patients
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education ACCME) through the joint providership of Your CE Source and CMM Global. Your CE Source is accredited by the ACCME to provide continuing medical education for physicians. Your CE Source designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Your CE Source is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #16031 for 1.25 contact hours.
The program is jointly provided by Your CE Source and CMM Global.
Program Faculty
Program Chair
Maria Fleseriu, MD, FACE
Professor of Medicine and Neurological Surgery
Director, Pituitary Center
Oregon Health & Science University
Portland, USA
Faculty Presenter
Andrew R. Hoffman, MD
Professor of Medicine, Endocrinology
Stanford Medical Center
Stanford, USA
Faculty Presenter
Gudmundur Johannsson, MD, PhD
Professor of Endocrinology
Deputy Director, Institute of Medicine
Sahlgrenska Academy, University of Gothenburg
Sweden
Faculty Presenter
Julie Silverstein, MD
Medical Director, Pituitary Center
Associate Professor of Medicine and Neurological Surgery
Division of Endocrinology, Metabolism and Lipid Research
Washington University School of Medicine
St. Louis, USA